In line with this rationale, a combined preclinical and clinical study [68] have reported that PD-L1 protein abundance and tumor-infiltrating lymphocyte is regulated by cell cycle kinases and that the Inhibition of CDK4/6 increases PD-L1 protein and reduced the numbers of tumor-infiltrating lymphocytes in mouse and in human cancer specimens. This evidence concerns the gene CD274 and neoplasm.